Inogen (INGN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.24 per share a year ago. These figures are ...
Zacks Investment Research on MSN
Here's why you should retain Inogen stock in your portfolio for now
Inogen, Inc. INGN is well-poised for growth in the coming quarters, backed by high prospects in the portable oxygen ...
BEVERLY, Mass. (AP) — BEVERLY, Mass. (AP) — Inogen Inc. (INGN) on Tuesday reported a loss of $7.1 million in its fourth quarter. The Beverly, Massachusetts-based company said it had a loss of 26 cents ...
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, unaudited revenue results for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results